Arcataur Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Arcataur Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$543K	Buy	1,083 +30	+3%	+$14.4K	0.13%	64
2026 Q1	$518K	Buy	1,053 +10	+1%	+$5.43K	0.14%	64
2025 Q4	$604K	Sell	1,043 -5	-0.5%	-$2.83K	0.17%	58
2025 Q3	$508K	Sell	1,048 -57	-5%	-$26.5K	0.15%	60
2025 Q2	$448K	Buy	1,105 +4	+0.4%	+$1.67K	0.14%	68
2025 Q1	$548K	Sell	1,101 -102	-8%	-$55.2K	0.19%	53
2024 Q4	$626K	Hold	1,203	–	–	0.21%	46
2024 Q3	$744K	Sell	1,203 -11	-0.9%	-$6.51K	0.25%	43
2024 Q2	$671K	Sell	1,214 -4	-0.3%	-$2.29K	0.24%	42
2024 Q1	$708K	Hold	1,218	–	–	0.25%	40
2023 Q4	$647K	Sell	1,218 -7	-0.6%	-$3.39K	0.25%	40
2023 Q3	$620K	Hold	1,225	–	–	0.26%	40
2023 Q2	$639K	Buy	+1,225	New	+$661K	0.26%	39

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Arcataur Capital Management's TMO Position: Q2 2026 in Review

Arcataur Capital Management increased its Thermo Fisher Scientific (TMO) stake by 2.8% in Q2 2026, buying an estimated $14.4K and bringing the position to 1,083 shares worth $543K. The position accounts for 0.13% of the portfolio, ranked #64.

Arcataur Capital Management first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $744K in Q3 2024. 2,022 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Arcataur Capital Management held 1,083 shares of Thermo Fisher Scientific worth $543K as of Q2 2026.
Arcataur Capital Management bought 30 Thermo Fisher Scientific shares in Q2 2026, an estimated $14.4K.
Thermo Fisher Scientific made up 0.13% of Arcataur Capital Management's portfolio in Q2 2026, its #64 holding.
Arcataur Capital Management first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
Arcataur Capital Management's Thermo Fisher Scientific position peaked at $744K in Q3 2024.
2,022 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Arcataur Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.